CervoMed(CRVO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CRVO CervoMed

盘后交易 07-31 16:45:01 EDT

2.58

+0.06

+2.38%

盘后2.57

-0.01-0.30%

16:30 EDT

最高2.60	最低2.46	成交量23.77万
今开2.51	昨收2.52	日振幅5.56%
总市值3,490万	流通市值2,225万	总股本1,353万
成交额59.73万	换手率2.76%	流通股本862.35万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CRVO","market":"US","secType":"STK","nameCN":"CervoMed","latestPrice":2.58,"timestamp":1785528000000,"preClose":2.52,"halted":0,"volume":237656,"hourTrading":{"tag":"盘后","latestPrice":2.5723,"preClose":2.58,"latestTime":"16:30 EDT","volume":351,"amount":905.572278,"timestamp":1785529856026,"change":-0.0077,"changeRate":-0.002984,"amplitude":0.002984},"delay":0,"changeRate":0.02380952380952383,"floatShares":8623466,"shares":13526200,"eps":-3.273729,"marketStatus":"盘后交易","change":0.06,"latestTime":"07-31 16:45:01 EDT","open":2.51,"high":2.6,"low":2.46,"amount":597285.5197536,"amplitude":0.055556,"askPrice":2.8,"askSize":100,"bidPrice":2.43,"bidSize":50,"shortable":3,"etf":0,"ttmEps":-3.273729,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1785542400000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":2.52,"preHourTrading":{"tag":"盘前","latestPrice":2.5557,"preClose":2.52,"latestTime":"09:21 EDT","volume":6727,"amount":17338.1711454,"timestamp":1785504078119,"change":0.0357,"changeRate":0.014167,"amplitude":0.059524},"postHourTrading":{"tag":"盘后","latestPrice":2.5723,"preClose":2.58,"latestTime":"16:30 EDT","volume":351,"amount":905.572278,"timestamp":1785529856026,"change":-0.0077,"changeRate":-0.002984,"amplitude":0.002984},"volumeRatio":0.849541},"requestUrl":"/m/hq/s/CRVO/wiki","defaultTab":"wiki","newsList":[{"id":"1144170029","title":"CervoMed 在 AAIC 2026 公布 Neflamapimod 治疗路易体痴呆的新临床、血浆生物标志物及影像学数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1144170029","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1144170029?lang=zh_cn&edition=full","pubTime":"2026-07-14 19:32","pubTimestamp":1784028776,"startTime":"0","endTime":"0","summary":"CervoMed 在 2026 年阿尔茨海默病协会国际会议上，公布了其药物 Neflamapimod 用于治疗路易体痴呆的最新研究成果。此次公布的数据涵盖了关键的临床疗效指标、创新的血浆生物标志物分析以及先进的神经影像学发现，为评估该疗法的潜力提供了多维度的证据支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170264182","title":"CervoMed宣布完成Neflamapimod针对非流利变异型原发性进行性失语症（一种额颞叶痴呆）的二期研究入组","url":"https://stock-news.laohu8.com/highlight/detail?id=1170264182","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170264182?lang=zh_cn&edition=full","pubTime":"2026-07-09 19:32","pubTimestamp":1783596724,"startTime":"0","endTime":"0","summary":"CervoMed已宣布，其药物Neflamapimod针对非流利变异型原发性进行性失语症（一种额颞叶痴呆）的第二阶段临床试验，现已成功完成患者入组工作。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132605708","title":"CervoMed完成1000万美元纳斯达克规则下普通股注册直接发行","url":"https://stock-news.laohu8.com/highlight/detail?id=1132605708","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1132605708?lang=zh_cn&edition=full","pubTime":"2026-06-23 04:05","pubTimestamp":1782158721,"startTime":"0","endTime":"0","summary":"CervoMed宣布，其已根据纳斯达克市场规则，完成一笔定价为市场价格的普通股注册直接发行，募集资金总额达1000万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146627967","title":"CervoMed宣布根据纳斯达克规则进行1000万美元普通股市场价注册直接发行","url":"https://stock-news.laohu8.com/highlight/detail?id=1146627967","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146627967?lang=zh_cn&edition=full","pubTime":"2026-06-19 00:36","pubTimestamp":1781800571,"startTime":"0","endTime":"0","summary":"CervoMed宣布，将根据纳斯达克规则进行一项价值1000万美元的普通股注册直接发行，发行价格将按市场价确定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121123878","title":"CervoMed宣布私募融资计划 将聚焦战略合作以推进Neflamapimod进入路易体痴呆症三期临床","url":"https://stock-news.laohu8.com/highlight/detail?id=1121123878","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1121123878?lang=zh_cn&edition=full","pubTime":"2026-06-10 19:30","pubTimestamp":1781091016,"startTime":"0","endTime":"0","summary":"CervoMed公司宣布了一项私募融资计划，并披露了其未来战略重心：公司将致力于寻求战略合作伙伴，以推动其核心候选药物Neflamapimod进入针对路易体痴呆症的第三阶段临床试验。这一举措旨在为关键性临床研究获取必要资源，加速该疗法的开发进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176804788","title":"CervoMed计划于2026年下半年启动Neflamapimod针对DLB患者的III期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1176804788","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176804788?lang=zh_cn&edition=full","pubTime":"2026-05-18 19:36","pubTimestamp":1779104183,"startTime":"0","endTime":"0","summary":"CervoMed公司宣布，计划在2026年下半年启动一项III期临床试验，旨在评估其候选药物Neflamapimod在路易体痴呆（DLB）患者中的疗效与安全性。这一举措标志着该药物研发进程中的重要一步，公司正积极推进其针对神经退行性疾病的治疗管线。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163917918","title":"CervoMed将于2026年路易体痴呆协会年会公布Neflamapimod临床项目进展并参与生物标志物专题讨论","url":"https://stock-news.laohu8.com/highlight/detail?id=1163917918","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163917918?lang=zh_cn&edition=full","pubTime":"2026-04-07 19:31","pubTimestamp":1775561473,"startTime":"0","endTime":"0","summary":"CervoMed宣布，公司计划在2026年路易体痴呆协会年度会议上，详细介绍其核心候选药物Neflamapimod的临床研发项目最新数据与进展。此外，CervoMed的研究专家还将受邀参与一场关于生物标志物的专题小组讨论，分享在该领域的见解与发现。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190106082","title":"CervoMed于2026年Ad/Pd™科学会议公布新数据，进一步证实Neflamapimod对无阿尔茨海默病共病理的路易体痴呆患者具有积极疗效","url":"https://stock-news.laohu8.com/highlight/detail?id=1190106082","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190106082?lang=zh_cn&edition=full","pubTime":"2026-03-19 19:33","pubTimestamp":1773920016,"startTime":"0","endTime":"0","summary":"CervoMed在2026年Ad/Pd™科学会议上公布了最新研究数据，这些数据强化了Neflamapimod药物对不伴有阿尔茨海默病共病理的路易体痴呆患者的治疗效果。新发现突显该疗法在特定患者群体中的显著优势，为精准医疗提供重要依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186895438","title":"CervoMed确定针对路易体痴呆症患者的三期临床试验配方及给药方案","url":"https://stock-news.laohu8.com/highlight/detail?id=1186895438","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186895438?lang=zh_cn&edition=full","pubTime":"2026-03-04 20:32","pubTimestamp":1772627574,"startTime":"0","endTime":"0","summary":"CervoMed已正式确定其针对路易体痴呆症患者的三期临床试验的最终配方及给药方案。这一关键决策标志着该公司在推进神经退行性疾病治疗研究方面迈出了重要一步，为后续临床试验的开展奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616287587","title":"Cervomed Inc.盘中异动 股价大涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616287587","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616287587?lang=zh_cn&edition=full","pubTime":"2026-03-04 03:07","pubTimestamp":1772564827,"startTime":"0","endTime":"0","summary":"北京时间2026年03月04日03时07分，Cervomed Inc.股票出现异动，股价快速上涨5.14%。截至发稿，该股报4.09美元/股，成交量5.2395万股，换手率0.57%，振幅7.67%。Cervomed Inc.股票所在的生物技术行业中，整体跌幅为1.90%。其相关个股中，Edesa Biotech, Inc.、Onconetix, Inc.、Calcimedica, Inc.涨幅较大，Edesa Biotech, Inc.、Adial Pharmaceuticals, Inc、Onconetix, Inc.较为活跃，换手率分别为296.56%、138.89%、128.97%，振幅较大的相关个股有Edesa Biotech, Inc.、Onconetix, Inc.、Yd Bio Ltd C/Wts 28/08/2030，振幅分别为76.32%、47.36%、43.99%。Cervomed Inc.公司简介：CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304030708a69ea6fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304030708a69ea6fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173716197","title":"CervoMed旗下Neflamapimod获选纳入英国Experts-ALS平台，旨在优先推进肌萎缩侧索硬化症的潜力疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=1173716197","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173716197?lang=zh_cn&edition=full","pubTime":"2026-02-18 19:02","pubTimestamp":1771412559,"startTime":"0","endTime":"0","summary":"CervoMed公司宣布，其研发的候选药物Neflamapimod已被遴选加入英国Experts-ALS平台。该平台的核心目标在于识别并优先推进针对肌萎缩侧索硬化症（ALS）最具前景的治疗方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512169419","title":"Cervomed Inc.盘中异动 早盘快速下跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512169419","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512169419?lang=zh_cn&edition=full","pubTime":"2025-02-18 23:05","pubTimestamp":1739891114,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日23时05分，Cervomed Inc.股票出现异动，股价大幅下跌5.15%。截至发稿，该股报2.21美元/股，成交量2.9744万股，换手率0.36%，振幅5.58%。Cervomed Inc.股票所在的生物技术行业中，整体涨幅为0.65%。其相关个股中，Solid Biosciences Inc.、Allogene Therapeutics, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Aditxt, Inc.、Solid Biosciences Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为333.39%、127.78%、119.54%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Jasper Therapeutics Inc C/Wts 24/09/2026 、Allogene Therapeutics, Inc.，振幅分别为41.79%、34.04%、33.58%。Cervomed Inc.公司简介：CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218230514a24ab453&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218230514a24ab453&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510360043","title":"Cervomed Inc.盘中异动 急速下跌5.02%报2.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510360043","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510360043?lang=zh_cn&edition=full","pubTime":"2025-02-11 23:45","pubTimestamp":1739288742,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日23时45分，Cervomed Inc.股票出现异动，股价急速下挫5.02%。截至发稿，该股报2.08美元/股，成交量2.9468万股，换手率0.36%，振幅4.80%。Cervomed Inc.股票所在的生物技术行业中，整体跌幅为1.85%。其相关个股中，Ocean Biomedical, Inc.、Lipella Pharmaceuticals Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为2719.51%、1098.32%、377.13%，振幅较大的相关个股有Dominari Holdings Inc.、Ocean Biomedical, Inc.、In8Bio, Inc.，振幅分别为58.60%、57.43%、40.87%。Cervomed Inc.公司简介：CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211234542a2420bec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211234542a2420bec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505045519","title":"Cervomed Inc.盘中异动 临近午盘股价大涨5.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505045519","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505045519?lang=zh_cn&edition=full","pubTime":"2025-01-24 00:40","pubTimestamp":1737650405,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日00时40分，Cervomed Inc.股票出现波动，股价大幅拉升5.50%。截至发稿，该股报2.30美元/股，成交量3.3895万股，换手率0.41%，振幅6.88%。Cervomed Inc.股票所在的生物技术行业中，整体涨幅为0.47%。其相关个股中，Dogwood Therapeutics, Inc.、Nutriband Inc C/Wts 、Exicure, Inc.涨幅较大，Hepion Pharmaceuticals, Inc.、Dogwood Therapeutics, Inc.、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为3599.77%、2463.29%、660.66%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Nutriband Inc C/Wts 、Jupiter Neurosciences, Inc.，振幅分别为246.43%、64.29%、55.57%。Cervomed Inc.公司简介：CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501240040059870d354&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501240040059870d354&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505392781","title":"Cervomed Inc.盘中异动 临近收盘快速上涨5.21%报2.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505392781","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505392781?lang=zh_cn&edition=full","pubTime":"2025-01-22 04:33","pubTimestamp":1737491581,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日04时33分，Cervomed Inc.股票出现波动，股价大幅上涨5.21%。截至发稿，该股报2.22美元/股，成交量6.6461万股，换手率0.81%，振幅5.92%。Cervomed Inc.股票所在的生物技术行业中，整体涨幅为1.85%。其相关个股中，Dogwood Therapeutics, Inc.、Camp4 Therapeutics Corporation、Channel Therapeutics Corporation涨幅较大，Dogwood Therapeutics, Inc.、Channel Therapeutics Corporation、Dermata Therapeutics, Inc.较为活跃，换手率分别为1615.85%、528.30%、191.03%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Channel Therapeutics Corporation、Revolution Medicines Inc C/Wts 17/12/2026 ，振幅分别为103.72%、96.32%、67.67%。Cervomed Inc.公司简介：CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122043301960bf5dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122043301960bf5dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502145703","title":"Cervomed Inc.盘中异动 股价大跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502145703","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502145703?lang=zh_cn&edition=full","pubTime":"2025-01-09 01:28","pubTimestamp":1736357332,"startTime":"0","endTime":"0","summary":"北京时间2025年01月09日01时28分，Cervomed Inc.股票出现异动，股价快速跳水5.16%。截至发稿，该股报2.19美元/股，成交量8.3998万股，换手率1.02%，振幅4.56%。Cervomed Inc.股票所在的生物技术行业中，整体涨幅为0.30%。其相关个股中，Sana Biotechnology, Inc.、Silo Pharma, Inc.、Vir Biotechnology, Inc.涨幅较大，Silo Pharma, Inc.、Nls Pharmaceutics Ltd.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为3430.46%、595.63%、588.02%，振幅较大的相关个股有Sana Biotechnology, Inc.、Silo Pharma, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为192.73%、143.11%、89.00%。Cervomed Inc.公司简介：CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250109012852985f965a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250109012852985f965a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501901259","title":"Cervomed Inc.盘中异动 股价大跌5.03%报2.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501901259","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501901259?lang=zh_cn&edition=full","pubTime":"2025-01-06 23:34","pubTimestamp":1736177699,"startTime":"0","endTime":"0","summary":"北京时间2025年01月06日23时34分，Cervomed Inc.股票出现波动，股价快速下跌5.03%。截至发稿，该股报2.21美元/股，成交量8.0961万股，换手率0.98%，振幅3.83%。Cervomed Inc.股票所在的生物技术行业中，整体涨幅为0.36%。其相关个股中，Scisparc Ltd.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 涨幅较大，Scisparc Ltd.、Cns Pharmaceuticals, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为1166.43%、306.55%、99.39%，振幅较大的相关个股有Scisparc Ltd.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 ，振幅分别为176.15%、71.31%、54.46%。Cervomed Inc.公司简介：CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106233459985cf371&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106233459985cf371&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2500114209","title":"Cervomed Inc.盘中异动 早盘大幅拉升5.83%报2.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500114209","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500114209?lang=zh_cn&edition=full","pubTime":"2025-01-03 22:41","pubTimestamp":1735915295,"startTime":"0","endTime":"0","summary":"北京时间2025年01月03日22时41分，Cervomed Inc.股票出现波动，股价急速拉升5.83%。截至发稿，该股报2.36美元/股，成交量7720股，换手率0.09%，振幅4.48%。Cervomed Inc.股票所在的生物技术行业中，整体涨幅为0.49%。其相关个股中，Apollomics Inc C/Wts 01/04/2028 、Cyclacel Pharmaceuticals, Inc.、Scorpius Holdings, Inc.涨幅较大，Scorpius Holdings, Inc.、Cyclacel Pharmaceuticals, Inc.、Onconetix, Inc.较为活跃，换手率分别为971.62%、752.32%、268.94%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Cyclacel Pharmaceuticals, Inc.、Scorpius Holdings, Inc.，振幅分别为121.56%、75.47%、48.07%。Cervomed Inc.公司简介：CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103224135985a3f9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103224135985a3f9a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2495717615","title":"Cervomed Inc.盘中异动 早盘快速跳水5.69%报2.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2495717615","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495717615?lang=zh_cn&edition=full","pubTime":"2024-12-31 22:30","pubTimestamp":1735655452,"startTime":"0","endTime":"0","summary":"北京时间2024年12月31日22时30分，Cervomed Inc.股票出现异动，股价快速下跌5.69%。截至发稿，该股报2.25美元/股，成交量3935股，换手率0.05%，振幅0.00%。Cervomed Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，知临集团、Onconetix, Inc.、Eyenovia, Inc.涨幅较大，Onconetix, Inc.、知临集团、Eyenovia, Inc.较为活跃，换手率分别为849.65%、617.36%、130.44%，振幅较大的相关个股有Eyenovia, Inc.、Onconetix, Inc.、Portage Biotech Inc.，振幅分别为18.27%、11.44%、10.12%。Cervomed Inc.公司简介：CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024123122305295f42d11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024123122305295f42d11&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2493664807","title":"Cervomed Inc.盘中异动 早盘股价大涨5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493664807","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493664807?lang=zh_cn&edition=full","pubTime":"2024-12-23 22:37","pubTimestamp":1734964647,"startTime":"0","endTime":"0","summary":"北京时间2024年12月23日22时37分，Cervomed Inc.股票出现波动，股价快速上涨5.35%。截至发稿，该股报2.35美元/股，成交量3.8195万股，换手率0.46%，振幅2.69%。Cervomed Inc.股票所在的生物技术行业中，整体涨幅为0.01%。其相关个股中，Traws Pharma, Inc.、Rapt Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大，Phio Pharmaceuticals Corp.、Gt Biopharma, Inc.、Traws Pharma, Inc.较为活跃，换手率分别为679.69%、459.33%、313.86%，振幅较大的相关个股有Gt Biopharma, Inc.、Rapt Therapeutics, Inc.、Traws Pharma, Inc.，振幅分别为43.97%、41.19%、39.04%。Cervomed Inc.公司简介：CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223223728a2050c74&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223223728a2050c74&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cervomed.com","stockEarnings":[{"period":"1week","weight":-0.0562},{"period":"1month","weight":-0.1871},{"period":"3month","weight":-0.3208},{"period":"6month","weight":-0.5107},{"period":"1year","weight":-0.7035},{"period":"ytd","weight":-0.681}],"compareEarnings":[{"period":"1week","weight":0.0048},{"period":"1month","weight":-0.0068},{"period":"3month","weight":0.0292},{"period":"6month","weight":0.0719},{"period":"1year","weight":0.169},{"period":"ytd","weight":0.0876}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"CervoMed Inc.最初于1995年1月10日根据内华达州法律注册成立，并于2015年6月18日在特拉华州重新注册成立。该公司是一家临床阶段的生物技术公司，专注于开发与年龄相关的神经系统疾病的治疗方法。他们的主要候选药物neflamapimod是一种在研的口服小分子药物，能够轻松穿过血脑屏障，并选择性地抑制p38α酶——一种神经炎症和突触功能障碍的关键驱动因素。通过靶向脑部退行性疾病的关键病理过程，neflamapimod有望逆转突触功能障碍，改善神经元健康，并延缓或阻止疾病进展。Neflamapimod目前正处于治疗路易体痴呆 (DLB)（其主要适应症）以及非流利型原发性进行性失语症 (nfvPPA)、类风湿性关节炎 (RAS) 和肌萎缩侧索硬化症 (ALS) 的临床开发阶段。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.023389},{"month":2,"riseRate":0.5,"avgChangeRate":0.085839},{"month":3,"riseRate":0.5,"avgChangeRate":0.326048},{"month":4,"riseRate":0.3,"avgChangeRate":-0.063988},{"month":5,"riseRate":0.4,"avgChangeRate":0.116259},{"month":6,"riseRate":0.1,"avgChangeRate":-0.109707},{"month":7,"riseRate":0.2,"avgChangeRate":-0.088864},{"month":8,"riseRate":0.666667,"avgChangeRate":0.076308},{"month":9,"riseRate":0.111111,"avgChangeRate":-0.117703},{"month":10,"riseRate":0.111111,"avgChangeRate":-0.039339},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.045938},{"month":12,"riseRate":0.3,"avgChangeRate":-0.206034}],"exchange":"NASDAQ","name":"CervoMed","nameEN":"CervoMed"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CervoMed(CRVO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供CervoMed(CRVO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"CervoMed,CRVO,CervoMed股票,CervoMed股票老虎,CervoMed股票老虎国际,CervoMed行情,CervoMed股票行情,CervoMed股价,CervoMed股市,CervoMed股票价格,CervoMed股票交易,CervoMed股票购买,CervoMed股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CervoMed(CRVO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供CervoMed(CRVO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}